Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development and validation of a CTNNB1‐associated metabolic prognostic model for hepatocellular carcinoma
Junyu Huo, Liqun Wu, Yunjin Zang
Journal of Cellular and Molecular Medicine (2020) Vol. 25, Iss. 2, pp. 1151-1165
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review
Endrit Shahini, Giuseppe Pasculli, Antonio Giovanni Solimando, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4286-4286
Open Access | Times Cited: 27
Identification of a Tumor Immunological Phenotype-Related Gene Signature for Predicting Prognosis, Immunotherapy Efficacy, and Drug Candidates in Hepatocellular Carcinoma
Yuqin Tang, Chengbin Guo, Yang Zhao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 36
The Use of ctDNA in the Diagnosis and Monitoring of Hepatocellular Carcinoma—Literature Review
Agnieszka Kopystecka, Rafał Patryn, Magdalena Leśniewska, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9342-9342
Open Access | Times Cited: 18
A Ferroptosis and Pyroptosis Molecular Subtype-Related Signature Applicable for Prognosis and Immune Microenvironment Estimation in Hepatocellular Carcinoma
Junyu Huo, Jinzhen Cai, Ge Guan, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 40
Targeting Wnt/β-Catenin Pathways in Primary Liver Tumours: From Microenvironment Signaling to Therapeutic Agents
Federico Selvaggi, Teresa Catalano, Roberto Cotellese, et al.
Cancers (2022) Vol. 14, Iss. 8, pp. 1912-1912
Open Access | Times Cited: 20
Construction and Validation of a Universal Applicable Prognostic Signature for Gastric Cancer Based on Seven Immune-Related Gene Correlated With Tumor Associated Macrophages
Junyu Huo, Liqun Wu, Yunjin Zang
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 24
Pyroptosis, apoptosis, and necroptosis molecular subtype derived prognostic signature universal applicable for gastric cancer-A large sample and multicenter retrospective analysis
Junyu Huo, Wenjie Xie, Xinyi Fan, et al.
Computers in Biology and Medicine (2022) Vol. 149, pp. 106037-106037
Closed Access | Times Cited: 14
TuBG1 promotes hepatocellular carcinoma via ATR/P53-apoptosis and cycling pathways
Yan Zhang, Zhenzhen Wang, An-Qi Han, et al.
Hepatobiliary & pancreatic diseases international (2023) Vol. 23, Iss. 2, pp. 195-209
Closed Access | Times Cited: 8
Construction and comprehensive analysis of a novel prognostic signature associated with pyroptosis molecular subtypes in patients with pancreatic adenocarcinoma
Qian Huang, Xingyu Peng, Qingqing Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Development of a prognostic model for anoikis and identifies hub genes in hepatocellular carcinoma
Zhiwei Zhong, Fuchun Xie, Jiajun Yin, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
TC2N Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma by Targeting the Wnt/β-Catenin Signaling Pathway
Yixia Lou, Jing Gu, Lei Zhu, et al.
Laboratory Investigation (2023) Vol. 103, Iss. 12, pp. 100260-100260
Closed Access | Times Cited: 7
Development and Validation of a Robust Immune-Related Prognostic Signature for Gastric Cancer
Junyu Huo, Liqun Wu, Yunjin Zang
Journal of Immunology Research (2021) Vol. 2021, pp. 1-24
Open Access | Times Cited: 16
Eleven immune-gene pairs signature associated with TP53 predicting the overall survival of gastric cancer: a retrospective analysis of large sample and multicenter from public database
Junyu Huo, Liqun Wu, Yunjin Zang
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 13
A Five-Gene Signature Associated With DNA Damage Repair Molecular Subtype Predict Overall Survival for Hepatocellular Carcinoma
Junyu Huo, Xinyi Fan, Bingxin Qi, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 9
A pathway-guided strategy identifies a metabolic signature for prognosis prediction and precision therapy for hepatocellular carcinoma
Qili Shi, Yizhe Liu, Mingxing Lu, et al.
Computers in Biology and Medicine (2022) Vol. 144, pp. 105376-105376
Open Access | Times Cited: 9
Comprehensive analysis of metabolic pathway activity subtypes derived prognostic signature in hepatocellular carcinoma
Junyu Huo, Jinzhen Cai, Liqun Wu
Cancer Medicine (2022) Vol. 12, Iss. 1, pp. 898-912
Open Access | Times Cited: 9
A cellular senescence-related classifier based on a tumorigenesis- and immune infiltration-guided strategy can predict prognosis, immunotherapy response, and candidate drugs in hepatocellular carcinoma
Yi Luo, Hao Liu, Hong Fu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9
The dual roles of circRNAs in Wnt/β-Catenin signaling and cancer progression
Waleed Hassan Almalki, Salem Salman Almujri
Pathology - Research and Practice (2024) Vol. 255, pp. 155132-155132
Closed Access | Times Cited: 1
The clinical relevance of epithelial‐mesenchymal transition and its correlations with tumorigenic immune infiltrates in hepatocellular carcinoma
Zhiqiang Qiu, Xiang Wang, Xiangwen Ji, et al.
Immunology (2022) Vol. 166, Iss. 2, pp. 185-196
Open Access | Times Cited: 7
Identification and Validation of a GPX4-Related Immune Prognostic Signature for Lung Adenocarcinoma
Zhenxing Feng, Bo Li, Qingliang Chen, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-24
Open Access | Times Cited: 7
Mutational and transcriptional alterations and clinicopathological factors predict the prognosis of stage I hepatocellular carcinoma
Zhiqiang Li, Hongqiang Gao, Lei Zhang, et al.
BMC Gastroenterology (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Identification of chromosomal instability-associated genes as hepatocellular carcinoma progression-related biomarkers to guide clinical diagnosis, prognosis and therapy
Yueyang Hu, Chuanyu Tang, Wen Zhu, et al.
Computers in Biology and Medicine (2022) Vol. 148, pp. 105896-105896
Closed Access | Times Cited: 6
Development and Validation of a Novel Metabolic-Related Signature Predicting Overall Survival for Pancreatic Cancer
Junyu Huo, Liqun Wu, Yunjin Zang
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 8
Early detection of hepatocellular carcinoma: roadmap for improvement
Jonathan Melendez-Torres, Amit G. Singal
Expert Review of Anticancer Therapy (2022) Vol. 22, Iss. 6, pp. 621-632
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top